MIKAJAKI secures CHF 2.4M and a partnership with Pallas Kliniken

Please login or
register
08.06.2020
symbolic picture eye

With EyeLib, Geneva-based MIKAJAKI is introducing a fully automated eye health diagnostic platform. The company has received CHF 2.4M in a pre-series A investment led by BlueOcean to accelerate the regulatory process. The startup has also inked a partnership with Pallas Kliniken, the largest ophthalmic clinic group in Switzerland.

Today, the field of ophthalmology is under pressure from an increasingly aging population, which is growing much faster than the number of health professionals. As a result, waiting times will continue to increase, leading to a higher chance for degraded prognoses of sight-threatening diseases.

MIKAJAKI developed EyeLib, a platform that will make eye clinics and health institutions much more efficient by reshaping the clinical pipeline. The EyeLib station delivers a full report, including optical prescription parameters and accurate objective diagnostics for most vision-threatening eye conditions, based on ultimate ophthalmic diagnostic devices, state-of-the-art robotics and artificial intelligence. Patient profiling enables customized follow-up and referrals to specialists if needed. The EyeLib saves time and money for all stakeholders in the eye healthcare ecosystem, including patients, doctors, opticals, researchers, pharmaceutical suppliers, as well as public and private insurers.

Funding to process toward certification
The startup, based at Fongit, has now obtained new funds from BlueOcean and a consortium of private ophthalmologist investors to finalize the regulatory process toward CE certification. “We are extremely proud of being able to demonstrate our revolutionary concept in such a short amount of time,” said Michael Assouline, President and Co-Founder of MIKAJAKI. “We are very grateful to BlueOcean for their partnership and are eager to promote this innovative diagnostic equipment as the new gold standard in ophthalmology,” added Jacky Hochner, CEO and Co-Founder of MIKAJAKI.

Partnership with Pallas Kliniken
In addition to the closing of its financing round, MIKAJAKI announced a partnership with Pallas Kliniken, a leading group of ophthalmology and eye surgery centers in German-speaking Switzerland. With a network of over 16 locations and 120 doctors and specialists, Pallas Kliniken provides a wide range of the most modern treatment methods. Pallas Kliniken treats over 150,000 patients every year.

The company has additional contracts with over ten large European ophthalmic centers and ophthalmic device manufacturers.

(Press release / RAN)

0Comments

More news about

Mikajaki SA

Company profiles on startup.ch

Mikajaki SA

rss